Evaluation of 28-day repeated oral dose toxicity of aluminum chloride in rats

• Published in: Drug and chemical toxicology (New York, N.Y. 1978) N.Y. 1978), 2022-05, Vol.45 (3), p.1088-1097
• Main Authors: Lim, Je-Oh, Jung, Tae-Yang, Lee, Se-Jin, Park, So-Won, Kim, Woong-Il, Park, Sung-Hyeuk, Kim, Je-Hein, Heo, Jeong-Doo, Kim, Yong-Bum, Shin, In-Sik, Kim, Jong-Choon
• Format: Article
• Language: English
• Subjects: Administration, Oral; Aluminum; Aluminum Chloride - toxicity; Animals; Female; Liver; Male; No-Observed-Adverse-Effect Level; rat; Rats; Rats, Sprague-Dawley; systemic toxicity; target organ; Triglycerides
• ISSN: 0148-0545; 1525-6014
• DOI: 10.1080/01480545.2020.1808670

The present study investigated the potential adverse effects of aluminum chloride (AlCl 3 ) following a 4-week repeated oral administration in Sprague-Dawley rats. The test article was administered once daily by gavage to male and female rats at dose levels of 0, 100, 300, and 900 mg/kg/day for 4 weeks. After administration of AlCl 3 at 900 mg/kg/day, treatment-related systemic toxicity manifested as significant increases in salivation incidence, neutrophil percentage, reticulocytes, serum triglyceride, adrenal gland and liver weights, and single-hepatocyte necrosis, as well as significant decreases in body weight gain, food intake, hemoglobin, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration (MCHC), lymphocyte percentage, serum total protein and albumin, and thymus weight in male rats; and significant increases in salivation incidence, serum triglyceride, and liver weight, as well as a significant decrease in lymphocyte percentage in female rats. At 300 mg/kg/day, a significant decrease in MCHC was found in male rats, but not in female rats. However, this finding was not toxicologically significant because the reduction was minimal and was not accompanied by changes in any other parameters. No treatment-related effects were observed in the 100 mg/kg/day group of both genders. Under the experimental conditions of this study, the target organs of AlCl 3 were determined to be the blood, liver, and thymus in rats. The no-observed-adverse-effect level was found to be 300 mg/kg/day in rats of both genders.